In healthcare, ungoverned AI is not a compliance footnote, it is a patient-safety and licensure risk. US providers and payers deploying AI must navigate FDA oversight of software as a medical device, HIPAA obligations on protected health information, clinical validation on their own patient population, and the ONC HTI-1 rule requiring transparency into decision-support algorithms. Bias that widens health inequity is both an ethical failure and a legal exposure. The governing principle is physician oversight: AI recommends, a licensed human decides and remains accountable. Build these controls into the deployment, not around it afterward.
Governance is the license to operate, not the brake on it
Healthcare AI sits inside the most heavily regulated environment of any commercial sector, and for good reason: outputs can influence diagnosis, coverage, and care. The FDA has cleared or authorized more than 950 AI-enabled medical devices, most in radiology, and treats many diagnostic algorithms as software as a medical device subject to premarket review. A model that crosses from decision support into automated diagnosis can trigger that pathway, and getting the classification wrong is a serious regulatory error.
Beyond the FDA, HIPAA governs every use of protected health information, and the ONC HTI-1 rule now requires certified health IT to expose source attributes of predictive decision-support interventions so clinicians can judge reliability. Layer on state medical-board expectations that a licensed clinician remains accountable, and the message is clear: governance is what lets the deployment stand up to an auditor, a plaintiff, or a regulator.
The framing that works is that governance is the license to operate. A well-governed program can deploy confidently because it can answer the hard questions: what is this model intended to do, on whose data was it validated, who signs off on its outputs, and how would we know if it started to fail. An ungoverned program cannot answer those questions and is one adverse event away from a halt. Treating audit trails, versioning, and human approval as kernel features rather than afterthoughts is what separates a program that scales from one that gets shut down.
Four control domains every deployment must satisfy
Map every AI use case against these domains before it touches a patient or a claim. A gap in any one can halt the program.
| Domain | Requirement | Control to implement |
|---|---|---|
| Regulatory (FDA) | Classify whether the tool is software as a medical device | Legal and regulatory review before deployment; document intended use |
| Privacy (HIPAA) | Protect PHI in training, inference, and vendor data flows | Business associate agreements, de-identification, access logging |
| Clinical validation | Prove performance on your own patient population | Local validation study, ongoing performance monitoring |
| Transparency (HTI-1) | Expose model source, inputs, and limitations to clinicians | Model cards, decision-support attribute disclosure |
| Equity and bias | Detect performance gaps across demographic groups | Subgroup performance audits, bias mitigation, drift monitoring |
Build the governance spine before scaling
- Stand up an AI governance committee with clinical, legal, compliance, informatics, and equity representation that reviews every use case before go-live.
- Require a regulatory classification memo for each model that states whether it is software as a medical device and why.
- Validate every clinical model on your own patient data before deployment, since vendor accuracy on their population does not transfer to yours.
- Publish a model card for each deployed tool covering intended use, training data, known limitations, and subgroup performance, satisfying HTI-1 transparency expectations.
- Instrument continuous monitoring for accuracy drift and subgroup performance gaps, with a defined threshold that triggers pause and review.
- Define a clear human-in-the-loop step for every consequential output, so a licensed clinician reviews and signs the reasoning rather than deferring to a black-box score, and record that sign-off for audit.
How healthcare AI governance fails
- Trusting vendor validation and skipping local validation, so a model that performed well elsewhere underperforms on your demographics.
- Treating HIPAA as a checkbox and letting PHI flow to a vendor without a business associate agreement or de-identification.
- Deploying diagnostic-adjacent tools without confirming FDA classification, risking an enforcement action or a forced withdrawal.
- Auditing for bias once at launch and never again, missing drift that quietly widens care gaps over months.
Governance is measurable
- Percentage of deployed models with a completed regulatory classification and local validation on file.
- Subgroup performance parity, measured as the gap in sensitivity or specificity across race, sex, and age cohorts.
- Model drift alerts raised and mean time to review, showing monitoring is live not decorative.
- Percentage of AI recommendations with a documented human clinician sign-off, confirming oversight is real.
Frequently asked questions
When does a healthcare AI tool become an FDA-regulated medical device?
Generally when it is intended to diagnose, treat, or drive a clinical decision without a clinician independently reviewing the basis. Pure administrative tools and many decision-support aids that let a clinician review the reasoning often fall outside device regulation, but classification requires a formal review, not a guess.
What does the HTI-1 rule require of predictive algorithms?
HTI-1 requires certified health IT to make source attributes of predictive decision-support interventions available to users, so clinicians can see the inputs, intended use, and known limitations and judge whether to rely on an output.
How do we prevent AI from worsening health inequity?
Run subgroup performance audits before deployment and on an ongoing basis, comparing accuracy across demographic groups, and set a threshold that pauses the tool when a gap appears. Bias in training data does not announce itself; you have to test for it continuously.
Related reading
Go deeper on this sector and topic.